Expression System: Recombinant expression in E. coli ensures scalable production. The His tag facilitates affinity chromatography purification.
Quality Control: Purity is confirmed via SDS-PAGE (>90% purity), though additional validation (e.g., mass spectrometry) is not reported .
Stability: Lyophilized powder is recommended for long-term storage, with working aliquots stored at 4°C for ≤1 week .
Bacteriocin Systems: Pectobacterium carotovorum produces bacteriocins like Carocin S2 (killer/immunity proteins) and Carocin S4 (DNase activity) . PC1_3642’s role in such systems remains unexplored.
Pathogenicity Factors: Proteins involved in virulence (e.g., plant cell-wall-degrading enzymes, biofilm formation) are critical for P. carotovorum’s pathogenicity . PC1_3642’s potential involvement in these pathways is speculative.
Research Tools: Used in ELISA assays for antibody detection or protein interaction studies .
Functional Studies: Potential use in investigating bacterial stress responses, membrane dynamics, or host-pathogen interactions.
Creative BioMart. (2025). Recombinant Full Length Pectobacterium Carotovorum Subsp. Carotovorum UPF0442 Protein PC1_3642.
Anagnostics. (2025). ELISA Recombinant Pectobacterium carotovorum subsp. carotovorum UPF0442 Protein PC1_3642.
Creative BioMart. (2025). pc1_3642.
GeneBioSystems. (2024). Recombinant Pectobacterium carotovorum subsp. carotovorum UPF0442 Protein PC1_3642.
KEGG: pct:PC1_3642
STRING: 561230.PC1_3642
PC1_3642 is a full-length protein (156 amino acids) from Pectobacterium carotovorum subsp. carotovorum, classified as a member of the UPF0442 protein family. This protein has the UniProt ID C6DEZ3. The "UPF" designation indicates it belongs to a family of proteins with unknown function that has been identified through computational analysis but lacks experimental characterization of its biological role .
The protein contains several predicted transmembrane domains, as suggested by its amino acid sequence, which includes multiple hydrophobic regions characteristic of membrane-associated proteins. Understanding these structural elements is crucial for designing appropriate experimental conditions when working with this protein.
The recombinant form of PC1_3642 is typically expressed in E. coli expression systems with an N-terminal His-tag for purification purposes. The expression construct contains the complete protein sequence (amino acids 1-156) fused to the tag .
For researchers planning expression experiments, it's important to note that:
The protein is typically provided as a lyophilized powder after purification
SDS-PAGE analysis typically confirms >90% purity
The protein is stabilized in Tris/PBS-based buffer with 6% trehalose at pH 8.0
Proper reconstitution typically involves deionized sterile water to reach 0.1-1.0 mg/mL concentration
Based on established protocols for similar recombinant proteins and specific information for PC1_3642, researchers should adhere to the following storage and handling guidelines:
| Storage Parameter | Recommendation |
|---|---|
| Long-term storage | -20°C to -80°C |
| Working aliquots | 4°C for up to one week |
| Reconstitution buffer | Deionized sterile water |
| Recommended concentration | 0.1-1.0 mg/mL |
| Cryoprotectant | 5-50% glycerol (final concentration) |
| Freeze-thaw cycles | Minimize; aliquot before freezing |
Researchers should centrifuge the vial briefly before opening to ensure contents are at the bottom. After reconstitution, adding glycerol (typically to 50% final concentration) and creating working aliquots is recommended to prevent protein degradation from repeated freeze-thaw cycles .
When investigating an uncharacterized protein like PC1_3642, researchers should employ a multi-faceted experimental design approach:
Sequence-based analysis:
Perform comprehensive bioinformatic analysis to identify conserved domains
Conduct phylogenetic analysis to identify evolutionary relationships with characterized proteins
Use structural prediction software to generate hypothetical 3D models
Localization studies:
Employ fluorescent tagging to determine subcellular localization
Use fractionation techniques to confirm membrane association predicted by the hydrophobic sequence elements
Interaction studies:
Perform pull-down assays using the His-tagged protein
Conduct bacterial two-hybrid screens to identify binding partners
Employ co-immunoprecipitation followed by mass spectrometry
Functional assays:
Generate gene deletion mutants in Pectobacterium carotovorum
Conduct complementation studies with the recombinant protein
Perform phenotypic characterization of mutants vs. wild-type
Each approach should be designed with appropriate controls to ensure reliable interpretation of the results and should follow the experimental design principles outlined in scientific research .
For structural characterization of PC1_3642, researchers should consider a sequential analytical approach:
Primary structure confirmation:
Mass spectrometry to confirm molecular weight and post-translational modifications
N-terminal sequencing to verify the intact protein
Peptide mapping after proteolytic digestion
Secondary structure analysis:
Circular dichroism (CD) spectroscopy to estimate α-helix and β-sheet content
Fourier-transform infrared spectroscopy (FTIR) as a complementary method
Tertiary structure investigation:
X-ray crystallography (requiring successful crystallization)
Nuclear magnetic resonance (NMR) for smaller domains
Cryo-electron microscopy for membrane-associated contexts
Conformational stability assessment:
Thermal shift assays to determine melting temperature
Chemical denaturation studies using intrinsic fluorescence
Each method provides complementary information, and results should be integrated to build a comprehensive structural model of the protein.
The amino acid sequence of PC1_3642 (MGLSLLWALLQDMALAAVPALGFAMVFNVPLKVLPYCALLGGVGHGVRFLAMHFGMNIEWASFLAAILIGIIGIRWSRWLLAHPKVFTVAAVIPMFPGISAYTAMISVVEISHLGYSEAL MSVMITNFLKASFIVGALSIGLSLPGIWLYRKRPGV) contains multiple hydrophobic regions suggesting potential membrane association . To investigate this characteristic, researchers should employ a systematic approach:
Computational prediction:
Use TMHMM, HMMTOP, or similar algorithms to predict transmembrane domains
Apply hydropathy plotting tools to visualize hydrophobic regions
Employ SignalP to identify potential signal sequences
Experimental verification:
Perform membrane fractionation studies in native Pectobacterium or recombinant systems
Conduct protease protection assays to determine topology
Use fluorescence microscopy with GFP-fusion constructs to visualize localization
Biophysical characterization:
Employ circular dichroism in the presence of membrane mimetics
Use differential scanning calorimetry to measure membrane interaction thermodynamics
Conduct tryptophan fluorescence studies to assess conformational changes upon membrane binding
This multi-method approach will provide robust evidence for or against membrane association and orientation.
Crystallizing membrane-associated proteins presents unique challenges due to their hydrophobic surfaces. For PC1_3642, researchers should consider these specialized approaches:
Construct optimization:
Design multiple constructs with varying boundaries to remove flexible regions
Create fusion proteins with crystallization chaperones (e.g., T4 lysozyme)
Consider removing the His-tag after purification if it introduces flexibility
Detergent screening:
Systematically test multiple detergent types (nonionic, zwitterionic, etc.)
Employ small-scale thermal stability assays to identify optimal detergent conditions
Consider novel amphiphiles like maltose-neopentyl glycol (MNG) compounds
Crystallization techniques:
Apply lipidic cubic phase methodologies for membrane proteins
Screen with robotics to maximize condition coverage with minimal protein
Implement microseeding to improve crystal quality and reproducibility
Alternative approaches:
Consider Cryo-EM for structure determination if crystallization proves challenging
Employ SAXS to obtain low-resolution envelopes in solution
Use NMR for structural analysis of specific domains
The success rates for membrane protein crystallization remain lower than for soluble proteins, requiring persistence and methodical optimization of conditions.
Identifying interaction partners is crucial for understanding the function of uncharacterized proteins like PC1_3642. A comprehensive experimental design should include:
Affinity-based approaches:
Perform His-tag pull-downs followed by mass spectrometry
Conduct cross-linking studies to capture transient interactions
Employ bacterial two-hybrid or yeast two-hybrid systems with appropriate controls
Proximity-based methods:
Utilize BioID or APEX2 proximity labeling in the native bacterial system
Implement FRET-based interaction assays for candidate partners
Apply co-immunoprecipitation with antibodies against the target protein
Computational prediction and validation:
Use protein-protein interaction prediction algorithms
Perform molecular docking with candidate partners
Validate high-confidence predictions with targeted biochemical assays
Functional validation:
Design mutagenesis experiments to disrupt predicted interfaces
Conduct competition assays with peptides derived from interaction interfaces
Perform functional assays to determine the biological significance of identified interactions
This integrated approach combines unbiased screening with targeted validation to identify physiologically relevant protein partners.
When facing contradictory results in PC1_3642 research, employ a systematic troubleshooting approach:
Experimental conditions assessment:
Evaluate buffer composition effects (pH, salt concentration, additives)
Test temperature-dependent activity profiles
Examine the impact of protein concentration on aggregation state
Sample quality verification:
Confirm protein integrity by SDS-PAGE before each experiment
Verify activity using established controls where possible
Assess batch-to-batch variation with standardized assays
Methodological validation:
Implement multiple orthogonal techniques to measure the same parameter
Conduct statistical analysis to determine significance of differences
Consider blinded experimental design to reduce experimenter bias
Biological context considerations:
Investigate how results might differ between in vitro and in vivo conditions
Consider post-translational modifications that might affect activity
Examine species-specific differences if comparing across organisms
Rigorous application of these principles will help distinguish true biological phenomena from experimental artifacts.
When the experimental characterization of PC1_3642 is limited, bioinformatic approaches can guide hypothesis development:
Sequence-based analysis:
Perform position-specific iterative BLAST (PSI-BLAST) to identify distant homologs
Use HMMER to search for conserved domains and motifs
Apply multiple sequence alignment to identify conserved residues across species
Structural prediction:
Generate 3D models using AlphaFold2 or RoseTTAFold
Identify potential ligand-binding pockets using CASTp or similar tools
Compare predicted structures with characterized proteins using Dali or VAST
Genomic context analysis:
Examine the organization of genes surrounding pc1_3642 in the genome
Identify potential operons or co-regulated genes
Perform phylogenetic profiling to find co-occurring genes across species
Integrated approaches:
Combine results from multiple prediction methods
Weight predictions based on confidence scores from each method
Develop testable hypotheses based on the highest-confidence predictions
These computational approaches should guide experimental design rather than replace it, providing a framework for targeted functional studies.
Proper experimental controls are essential for reliable characterization of PC1_3642:
Protein quality controls:
Include denatured protein samples to establish baseline for activity assays
Use site-directed mutants of predicted catalytic residues
Prepare tag-only controls to distinguish tag artifacts from protein-specific effects
Experimental condition controls:
Include buffer-only controls in all assays
Perform time-course studies to ensure measurements within linear range
Test multiple protein concentrations to identify concentration-dependent effects
Positive and negative controls:
Include well-characterized proteins from the same family when possible
Use unrelated proteins of similar size and properties as negative controls
Implement internal standards appropriate for each analytical method
Validation controls:
Repeat critical experiments with independent protein preparations
Verify key findings using alternative methodological approaches
Consider blind sample coding for subjective measurements
Thorough implementation of these controls enhances data reliability and facilitates proper interpretation of results.
To study PC1_3642 in its native bacterial context, researchers should implement a multi-level experimental design:
Genetic manipulation approaches:
Generate clean deletion mutants using allelic exchange
Create conditional expression systems for essential genes
Develop complementation strains with wild-type and mutant variants
Expression analysis:
Perform quantitative RT-PCR to measure transcript levels
Use reporter gene fusions to study promoter activity
Implement RNA-seq to identify co-regulated genes
Functional phenotyping:
Conduct comprehensive growth curve analysis under various conditions
Test virulence in appropriate plant host models
Perform metabolomic profiling to identify affected pathways
Proteomic investigation:
Implement targeted proteomics to measure PC1_3642 levels
Conduct comparative proteomics between wild-type and mutant strains
Use protein complexome profiling to identify native protein complexes
This multi-faceted approach follows established principles for bacterial genetics and functional genomics, applying techniques from one-shot case studies to more complex pretest-posttest experimental designs .